Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

MiMedx Group Inc

MDXG ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Small Cap Analyst: BUY

Last Close

$4.27

▲ +1.67%

Market Cap $622.40M · Vol 266.53K

Key Metrics

P/E Ratio

108.13

FWD: N/A

Market Cap

$622.40M

Small Cap

Div Yield

N/A

EPS Growth

-142.97%

YoY

RSI (14)

50.43

Momentum

Beta

1.41

vs Market

52W High

$7.97

46.42% below

52W Low

$3.03

41.16% above

Volume

266.53K

Avg 470.53K

P/B

3.91

Price-to-book

ROE

N/A

Return on equity

Free Float

97.87%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, MiMedx Group Inc (MDXG) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does MDXG pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-1.61%

+1.67%

+20.28%

-16.60%

YTD

-36.93%

-40.28%

-42.99%

-64.48%

Financials & Valuation

TTM · Annual

Total Revenue	$418.63M
Net Income	$48.58M
Revenue Growth (YoY)	-34.73%
Gross Margin	82.45%
Operating Margin	15.26%
Net Profit Margin	11.60%
ROE	N/A
ROA · ROIC	21.85% · 20.51%

P/E Ratio	108.13
Forward P/E (FY1)	N/A
PEG Ratio	1.38
P/S	2.42
P/B	3.91
P/FCF	13.89
EPS Growth	-142.97%
Outstanding Shares	145.76M

Technical Indicators

50-Day SMA	$4.04
200-Day SMA	$4.94
RSI (14)	50.43
Beta	1.41
52-Week High	$7.97
52-Week Low	$3.03

Volume Today	266.53K
Avg Daily Volume (30D)	470.53K
Relative Volume	0.57x
Volatility (10D)	32.52
Volatility (30D)	35.40
Free Float	97.87%

Analyst Consensus

BUY

Current Price $4.27

Mean Target $7.00

52W Low$3.03 52W High$7.97

Current

Target

$3.03 $7.97

Current Analyst target

+63.93% upside potential · 5 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001STPW96

ISINUS6024961012

CountryUnited States of America

Sub-IndustryBio Medical Devices

Earnings DateOct 27, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

BONS.TA Bonus Biogroup Ltd -1.35% ALNOV.PA Novacyt SA +0.78% BBLG Bone Biologics Corp -2.86% 2359.HK WuXi AppTec Co Ltd -2.85% ARGX argenx SE -0.66%

Company Profile

MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.